AMERICA'S #1 OPHTHALMIC PHARMACY
LIVE

Serial Number

97525916

Owner

HARROW IP, LLC

Attorney

Laila S. Wolfgram

First Use Date

Feb 8, 2023

Filing Date

Jul 29, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AMERICA'S #1 OPHTHALMIC PHARMACY Trademark

Serial Number: 97525916 • Registration: 7430568

AMERICA'S #1 OPHTHALMIC PHARMACY is a trademark filed by HARROW IP, LLC on July 29, 2022. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

HARROW IP, LLC (199 trademarks)

102 WOODMONT BLVD., STE 610
NASHVILLE, TN 372052221

Entity Type: 16

Trademark Details

Filing Date

July 29, 2022

Registration Date

June 25, 2024

First Use Anywhere

February 8, 2023

First Use in Commerce

February 8, 2023

Goods & Services

Internet-based health care information services; telemedicine services; providing health care information by telephone and the internet; web-based health assessment services, namely, a series of health-related questions for response from the user that result in a report that provides health-related information in the form of recommended educational resources and treatment information; health care services, namely, providing a database in the field of eye health care information that features data and information all for treatment and diagnostic purposes; health screening in the field of ophthalmic services

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 25, 2024 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Jun 25, 2024 R.SR
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
May 23, 2024 AAUA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
May 22, 2024 CNTA
USE AMENDMENT ACCEPTED
May 22, 2024 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
May 20, 2024 AUPC
ASSIGNED TO LIE
May 20, 2024 ALIE
ASSIGNED TO LIE
May 20, 2024 ALIE
EXAMINER'S AMENDMENT ENTERED
Feb 28, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 28, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 28, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 28, 2024 CNEA
USE AMENDMENT FILED
Jan 31, 2024 IUAF
TEAS AMENDMENT OF USE RECEIVED
Jan 31, 2024 EAAU
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 31, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 31, 2024 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 31, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 31, 2023 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 31, 2023 GNFN
FINAL REFUSAL E-MAILED
Jul 31, 2023 GNFR
FINAL REFUSAL WRITTEN
Jul 31, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 12, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 12, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 12, 2023 TROA
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Apr 12, 2023 ASCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 10, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 10, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 10, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 24, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 2, 2022 NWOS
NEW APPLICATION ENTERED
Aug 2, 2022 NWAP